NO972435L - 2-(2,3,5,6-tetrafluor-4-pyridyl)-1,2,5-tradiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav - Google Patents

2-(2,3,5,6-tetrafluor-4-pyridyl)-1,2,5-tradiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav

Info

Publication number
NO972435L
NO972435L NO972435A NO972435A NO972435L NO 972435 L NO972435 L NO 972435L NO 972435 A NO972435 A NO 972435A NO 972435 A NO972435 A NO 972435A NO 972435 L NO972435 L NO 972435L
Authority
NO
Norway
Prior art keywords
dioxides
pyridyl
methods
tradiazolidin
tetrafluoro
Prior art date
Application number
NO972435A
Other languages
English (en)
Norwegian (no)
Other versions
NO972435D0 (no
Inventor
Ranjit C Desai
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of NO972435D0 publication Critical patent/NO972435D0/no
Publication of NO972435L publication Critical patent/NO972435L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO972435A 1994-12-02 1997-05-28 2-(2,3,5,6-tetrafluor-4-pyridyl)-1,2,5-tradiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav NO972435L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/348,439 US5750546A (en) 1994-12-02 1994-12-02 2-(2, 3, 5, 6-tetrafluoro-4-pyridyl)-1, 2, 5-thiadiazolidin-3-one 1, 1-dioxides and compositions and method of use thereof
PCT/US1995/015562 WO1996016654A1 (en) 1994-12-02 1995-11-30 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof

Publications (2)

Publication Number Publication Date
NO972435D0 NO972435D0 (no) 1997-05-28
NO972435L true NO972435L (no) 1997-05-28

Family

ID=23368062

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972435A NO972435L (no) 1994-12-02 1997-05-28 2-(2,3,5,6-tetrafluor-4-pyridyl)-1,2,5-tradiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav

Country Status (12)

Country Link
US (2) US5750546A (es)
EP (1) EP0792150A4 (es)
JP (1) JPH10510534A (es)
CN (1) CN1173131A (es)
AU (1) AU704858B2 (es)
CA (1) CA2205800A1 (es)
FI (1) FI972307A0 (es)
HU (1) HUT77091A (es)
MX (1) MX9704036A (es)
NO (1) NO972435L (es)
NZ (1) NZ300041A (es)
WO (1) WO1996016654A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420401B1 (en) * 1997-08-22 2002-07-16 Wichita State University 1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives
AU2003300447B2 (en) * 2002-12-30 2009-09-03 Vertex Pharmaceuticals Incorporated Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders
MY174415A (en) * 2015-10-26 2020-04-17 Jiangsu Kanion Parmaceutical Co Ltd Salt form, crystal form and intermediate of 1,2,5-thiadiazolidine-1,1-dioxide and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369183A (en) * 1979-09-06 1983-01-18 Merck & Co., Inc. 2-Pyridyl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
DE4141218A1 (de) * 1991-12-13 1993-06-17 Luitpold Werk Chem Pharm Thiadiazincarbonsaeureamidderivate, verfahren zu ihrer herstellung und arzneimittel
US5550139A (en) * 1994-01-03 1996-08-27 The Wichita State University Serine protease inhibitors
US5455255A (en) * 1994-02-07 1995-10-03 Sterling Winthrop Inc. 2-(2,3,5,6-tetrafluoro-4-pyridyl)-1,2-benzisothiazol-3(2H)-one 1,1-dioxides and compositions and method of use thereof

Also Published As

Publication number Publication date
MX9704036A (es) 1998-02-28
FI972307A7 (fi) 1997-05-30
NO972435D0 (no) 1997-05-28
NZ300041A (en) 1999-06-29
AU704858B2 (en) 1999-05-06
AU4623796A (en) 1996-06-19
EP0792150A4 (en) 1998-03-11
WO1996016654A1 (en) 1996-06-06
EP0792150A1 (en) 1997-09-03
CA2205800A1 (en) 1996-06-06
HUT77091A (hu) 1998-03-02
JPH10510534A (ja) 1998-10-13
CN1173131A (zh) 1998-02-11
US5602154A (en) 1997-02-11
FI972307L (fi) 1997-05-30
FI972307A0 (fi) 1997-05-30
US5750546A (en) 1998-05-12

Similar Documents

Publication Publication Date Title
NO972451L (no) Heterosyklyloksy- og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksyder og preparater og fremgangsmåte for anvendelse derav
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
FI940378A0 (fi) 5-jäseniset heterosyklit, menetelmä niiden valmistamiseksi ja näitä yhdisteitä sisältävät lääkeaineet
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
ATE383167T1 (de) Zusammensetzungen welche dna zerstoerende agentien und p53 enthalten
FI962557A0 (fi) PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa
NO932620L (no) Amindiol-proteaseinhibitorer
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ATE208777T1 (de) (a)-annelierte pyrrolderivate und deren anwendung in der pharmazie
PT741716E (pt) Analogos de delta 12,13-iso-taxol sua utilizacao anti-neoplasica e composicoes farmaceuticas que os contem
AU2672895A (en) (a)-annelated pyrrole derivatives and pharmaceutical use thereof
NO940524D0 (no) Kondenserte 5-leddete heterocykler, fremgangsmåte for deres fremstilling, og legemidler inneholdende disse forbindelser
NO972449L (no) Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav
MA22495A1 (fr) Derives d'amidinophenylalanine, procede pour leur preparation et leur utilisation
IL120443A0 (en) Heterocyclic compounds for the treatment of pancreatitis
SE9600120D0 (sv) Novel medical use
NO20000519L (no) 2-acylaminopropanaminer som takykininreseptorantagonister
NO972450L (no) Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav
NO972435L (no) 2-(2,3,5,6-tetrafluor-4-pyridyl)-1,2,5-tradiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
DK131188A (da) 3-(2-halogenalkyl)-1,4-oxathiiner og 2(2-halogenalkyl)-1,4-dithiiner, samt farmaceutiske praeparater indeholdende disse til behandling af leukaemi og tumorer
ID20165A (id) Penggunaan asam 2-(3,4-dimetoksisinamoil)aminobenzoat untuk pembuatan obat untuk pengobatan atau pencegahan restenosis
RU95102147A (ru) Производные 1-[2-(1н-инден-3-ил)этил]-4-(нафт-1-ил)пиперазина, способ их получения и содержащие их медикамент и фармацевтический состав
NO961180D0 (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
ATE328597T1 (de) Arzneimittel zur verminderung der effekte während oder nach der menopause und verfahren tur behandlung under verwendung derselben
DK130293D0 (da) Benzox(thi)azine derivatives, pharmaceutical compositions thereof, and method of treating therewith